359 related articles for article (PubMed ID: 23295464)
1. The role of pigment epithelium-derived factor in the pathophysiology and treatment of ovarian hyperstimulation syndrome in mice.
Chuderland D; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Ron-El R; Shalgi R
J Clin Endocrinol Metab; 2013 Feb; 98(2):E258-66. PubMed ID: 23295464
[TBL] [Abstract][Full Text] [Related]
2. GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells.
Miller I; Chuderland D; Ron-El R; Shalgi R; Ben-Ami I
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1428-36. PubMed ID: 26308290
[TBL] [Abstract][Full Text] [Related]
3. The Dual Role of PEDF in the Pathogenesis of OHSS: Negating Both Angiogenic and Inflammatory Pathways.
Miller I; Chuderland D; Grossman H; Ron-El R; Ben-Ami I; Shalgi R
J Clin Endocrinol Metab; 2016 Dec; 101(12):4699-4709. PubMed ID: 27680872
[TBL] [Abstract][Full Text] [Related]
4. A physiological approach for treating endometriosis by recombinant pigment epithelium-derived factor (PEDF).
Chuderland D; Hasky N; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Shalgi R
Hum Reprod; 2013 Jun; 28(6):1626-34. PubMed ID: 23466670
[TBL] [Abstract][Full Text] [Related]
5. Effect of kisspeptin-54 on ovarian levels of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in an experimental model of ovarian hyperstimulation syndrome (OHSS).
Birinci H; Vatansever HS; Yüncü M
Reprod Fertil Dev; 2021 Nov; 33(16):799-809. PubMed ID: 34610858
[TBL] [Abstract][Full Text] [Related]
6. Pigment epithelium-derived factor (PEDF) negates hyperandrogenic PCOS features.
Miller I; Bar-Joseph H; Nemerovsky L; Ben-Ami I; Shalgi R
J Endocrinol; 2020 May; 245(2):291-300. PubMed ID: 32171180
[TBL] [Abstract][Full Text] [Related]
7. Hormonal regulation of pigment epithelium-derived factor (PEDF) in granulosa cells.
Chuderland D; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Komsky A; Satchi-Fainaro R; Eldar-Boock A; Ron-El R; Shalgi R
Mol Hum Reprod; 2013 Feb; 19(2):72-81. PubMed ID: 23075882
[TBL] [Abstract][Full Text] [Related]
8. Pigment epithelium-derived factor regulation by human chorionic gonadotropin in granulosa cells.
Bar-Joseph H; Ben-Ami I; Ron-El R; Shalgi R; Chuderland D
Reproduction; 2016 Feb; 151(2):179-85. PubMed ID: 26612427
[TBL] [Abstract][Full Text] [Related]
9. Role of pigment epithelium-derived factor in the reproductive system.
Chuderland D; Ben-Ami I; Bar-Joseph H; Shalgi R
Reproduction; 2014 Oct; 148(4):R53-61. PubMed ID: 25049425
[TBL] [Abstract][Full Text] [Related]
10. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor exerts antioxidative effects in granulosa cells.
Bar-Joseph H; Ben-Ami I; Ron-El R; Shalgi R; Chuderland D
Fertil Steril; 2014 Sep; 102(3):891-898.e3. PubMed ID: 25064413
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of letrozole and cabergoline on vascular permeability, ovarian diameter, ovarian tissue VEGF levels, and blood PEDF levels, in a rat model of ovarian hyperstimulation syndrome.
Şahin N; Apaydın N; Töz E; Sivrikoz ON; Genç M; Turan GA; Cengiz H; Eskicioğlu F
Arch Gynecol Obstet; 2016 May; 293(5):1101-6. PubMed ID: 26690356
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic vitamin D supplementation in ovarian hyperstimulation syndrome: an animal study.
Turan GA; Eskicioglu F; Sivrikoz ON; Cengiz H; Gur EB; Tatar S; Sahin N; Yilmaz O
Arch Gynecol Obstet; 2015 Aug; 292(2):421-7. PubMed ID: 25618750
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the role of pigment epithelium-derived factor (PEDF) in metabolic PCOS models.
Silber M; Miller I; Bar-Joseph H; Ben-Ami I; Shalgi R
J Endocrinol; 2020 Feb; 244(2):297-308. PubMed ID: 31661672
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists.
Ferrero H; García-Pascual CM; Gaytán M; Morales C; Simón C; Gaytán F; Pellicer A; Gómez R
Fertil Steril; 2014 Nov; 102(5):1468-1476.e1. PubMed ID: 25217874
[TBL] [Abstract][Full Text] [Related]
16. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model.
Wei LH; Chou CH; Chen MW; Rose-John S; Kuo ML; Chen SU; Yang YS
J Clin Endocrinol Metab; 2013 Mar; 98(3):E472-84. PubMed ID: 23348396
[TBL] [Abstract][Full Text] [Related]
17. Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model.
Yang H; Xu Z; Iuvone PM; Grossniklaus HE
Mol Vis; 2006 May; 12():511-7. PubMed ID: 16735992
[TBL] [Abstract][Full Text] [Related]
18. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
[TBL] [Abstract][Full Text] [Related]
19. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
Rizk B; Aboulghar M; Smitz J; Ron-El R
Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
[TBL] [Abstract][Full Text] [Related]
20. Pigment-Epithelium Derived Factor (PEDF) and the human ovary: a role in the generation of ROS in granulosa cells.
Kampfer C; Saller S; Windschüttl S; Berg D; Berg U; Mayerhofer A
Life Sci; 2014 Mar; 97(2):129-36. PubMed ID: 24361362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
